Represented Prometheus Laboratories, Inc. owner of an Orange Book listed branded drug, Lotronex (alosetron hydrochloride), indicated for women with severe Irritable Bowel Syndrome. Prometheus Labs bought the franchise from GSK several years ago, however US Patent No. 6,284,770 drawn to a method for treatment was not listed in the Orange Book. A reexamination strategy was devised to ensure patentability of the claims that covered the indication. After an initial PTO action denying the reexamination request, a petition was filed citing further relevant facts. Thereafter, the petition was granted. After successful prosecution of amended claims, a reexamination certificate issued providing valid patent coverage for Lotronex. The reexamined patent is now listed in the Orange Book.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Acquisition advice for a worldwide manufacturer of pool and recreational products
Represented a large, worldwide manufacturer of pool and recreational products that sought to acquire an early-stage company whose initial products more
Intellectual property protection for one of the world's leading entertainment technology companies
Serves as intellectual property counsel for one of the world's leading entertainment technology companies overseeing protection of intellectual more
Kevin Boylan and Bruce Newberg v. Golden Gate Doughnuts, LLC, Krispy Kreme Doughnut Inc., Scott Livengood and Brad Bruckman
The firm served as co-counsel for Krispy Kreme Doughnuts, Inc. defending claims of breach of contract, fraud, unfair and deceptive trade practices, more
Acquisition for U.S. and Canadian architectural and construction products company
Represented a U.S. and Canadian architectural and construction products company in an acquisition. more